Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
We present a case of multidrug-resistant Cytomegalovirus (CMV) and the use of maribavir, a novel oral treatment of resistant CMV, in a nontransplant immunocompromised host. Our patient initially was diagnosed with CMV pharyngitis on biopsy. Although his initial CMV pharyngitis resolved, the CMV isol...
Saved in:
| Main Authors: | Diana Zarowin, Jared Coe, Maxwell Bressman, Paul Riska, Philip Yune, Ghaleb Halaseh, Matthew J. Akiyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-06-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2023.1153 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population Pharmacokinetics and Exposure–Response Relationships of Maribavir in Transplant Recipients With First Episode or Refractory Cytomegalovirus
by: Kefeng Sun, et al.
Published: (2025-08-01) -
Case Report: Maribavir for refractory cytomegalovirus viremia after renal transplantation in a child with Schimke’s immune-osseous dysplasia
by: Jia-Shuan Huang, et al.
Published: (2025-04-01) -
Dual Resistance to Maribavir and Ganciclovir in Transplant Recipients
by: Steven B. Kleiboeker
Published: (2025-03-01) -
Multidrug-Resistant Bacteria in Immunocompromised Patients
by: Alexandru Duhaniuc, et al.
Published: (2024-08-01) -
Combined Cytomegalovirus Retinitis and Vitreous Hemorrhage in an Immunocompromised Patient
by: Abdulrahman Y. Alhoumaily, et al.
Published: (2025-01-01)